Qiagenは2025年第4四半期に予想を上回り,2026年の予測を上げ,分析者の反応は様々でした. Qiagen beat earnings expectations in Q4 2025, raised 2026 guidance, and saw mixed analyst reactions.

Qiagenは2026年2月4日に予想以上に強いQ4の利益を報告し,0.62ドルのEPSと5億4千4200万ドルの収益を上げ,同比3.6%増加した. Qiagen reported stronger-than-expected Q4 earnings on February 4, 2026, with $0.62 EPS and $540.42 million in revenue, up 3.6% year-over-year. 同社は2026年度の全収入ガイドラインを1株あたり15,000ドル,第4回の見通しを0.54ドルに上げた. The company raised its full-year 2026 earnings guidance to $2.50 per share and its first-quarter outlook to $0.54. JPMモーガンは60ドルに値上げし 潜在的な逆転を示唆し Citigroupは目標を55ドルに下げた JPMorgan raised its price target to $60, citing potential upside, while Citigroup lowered its target to $55.00. 株価は51.19ドルで,市価は108億ドルで,総評は"持てる"とされている. The stock, trading around $51.19, has a market cap of $10.8 billion and a consensus "hold" rating.